W.L. Ross & Co’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Other funds holding XENE
ACM
W.L. Ross & Co's XENE Position: Q2 2019 in Review
W.L. Ross & Co sold out of Xenon Pharmaceuticals (XENE) in Q2 2019, closing a stake of 79,539 shares — an estimated $808K sold.
W.L. Ross & Co first reported a position in XENE in Q4 2014 and held it in 18 quarters. The position peaked at $8.78M in Q4 2014. 60 funds tracked by Wall St. Rank hold XENE as of Q2 2019.
- W.L. Ross & Co reported no remaining Xenon Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
- W.L. Ross & Co sold 79,539 Xenon Pharmaceuticals shares in Q2 2019, an estimated $808K.
- W.L. Ross & Co first reported a position in Xenon Pharmaceuticals in Q4 2014 and held it in 18 quarters.
- W.L. Ross & Co's Xenon Pharmaceuticals position peaked at $8.78M in Q4 2014.
- 60 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2019.
Based on W.L. Ross & Co's 13F filing for Q2 2019, filed 14 Aug 2019.